As of 2025-07-14, the Relative Valuation of ALX Oncology Holdings Inc (ALXO) is (52.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.48 USD, the upside of ALX Oncology Holdings Inc based on Relative Valuation is -11065.8%.
The range of the Relative Valuation is (43.40) - (58.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 24.2x | 20.2x |
| Forward P/E multiples | 17.8x - 28.8x | 23.3x |
| Fair Price | (43.40) - (58.77) | (52.91) |
| Upside | -9094.4% - -12280.8% | -11065.8% |
| Date | P/E |
| 2025-07-11 | -0.20 |
| 2025-07-10 | -0.20 |
| 2025-07-09 | -0.21 |
| 2025-07-08 | -0.19 |
| 2025-07-07 | -0.18 |
| 2025-07-03 | -0.19 |
| 2025-07-02 | -0.18 |
| 2025-07-01 | -0.18 |
| 2025-06-30 | -0.17 |
| 2025-06-27 | -0.17 |
| 2025-06-26 | -0.19 |
| 2025-06-25 | -0.19 |
| 2025-06-24 | -0.19 |
| 2025-06-23 | -0.19 |
| 2025-06-20 | -0.20 |
| 2025-06-18 | -0.20 |
| 2025-06-17 | -0.20 |
| 2025-06-16 | -0.22 |
| 2025-06-13 | -0.21 |
| 2025-06-12 | -0.22 |
| 2025-06-11 | -0.23 |
| 2025-06-10 | -0.22 |
| 2025-06-09 | -0.24 |
| 2025-06-06 | -0.24 |
| 2025-06-05 | -0.22 |
| 2025-06-04 | -0.22 |
| 2025-06-03 | -0.23 |
| 2025-06-02 | -0.23 |
| 2025-05-30 | -0.20 |
| 2025-05-29 | -0.19 |
| 2025-05-28 | -0.18 |
| 2025-05-27 | -0.18 |
| 2025-05-23 | -0.19 |
| 2025-05-22 | -0.20 |
| 2025-05-21 | -0.17 |
| 2025-05-20 | -0.18 |
| 2025-05-19 | -0.18 |
| 2025-05-16 | -0.18 |
| 2025-05-15 | -0.18 |
| 2025-05-14 | -0.19 |
| 2025-05-13 | -0.20 |
| 2025-05-12 | -0.18 |
| 2025-05-09 | -0.17 |
| 2025-05-08 | -0.19 |
| 2025-05-07 | -0.20 |
| 2025-05-06 | -0.21 |
| 2025-05-05 | -0.23 |
| 2025-05-02 | -0.22 |
| 2025-05-01 | -0.21 |
| 2025-04-30 | -0.22 |